Effects of intravenous arginine vasopressin on epicardial coronary artery cross sectional area in a swine resuscitation model.
Although arginine vasopressin (AVP) has been shown to be a promising drug during cardiopulmonary resuscitation (CPR), concern has been raised about the potential for AVP-mediated vasoconstriction of the coronary arteries. In a prospective, randomized laboratory investigation employing an established porcine model, the effects of AVP on haemodynamic variables, left anterior descending (LAD) coronary artery cross sectional area employing intravascular ultrasound (IVUS), and return of spontaneous circulation were studied. During sinus rhythm, the LAD coronary artery cross sectional area was measured by IVUS at baseline, and 90 s and 5 min after AVP (0.4 U/kg IV). Following a 60 min recovery, ventricular fibrillation was induced. At 4 min, chest compressions were initiated; AVP (0.4 U/kg IV) was injected at 5.5 min, and defibrillation performed at 8 min. LAD coronary artery cross sectional area was measured by IVUS at the pre-arrest baseline, 90 s after drug injection during CPR, and 5 min after return of spontaneous circulation. Compared with baseline, the mid-LAD coronary artery cross sectional area increased significantly (P<.05) 90 s and 5 min after AVP administration (9.2+/-.5mm2 versus 10.7+/-.6mm2 versus 11.7+/-.6mm2, respectively) during normal sinus rhythm. Similarly during ventricular fibrillation and CPR plus AVP, the mid-LAD coronary artery cross sectional area increased at 90 s after AVP compared with baseline (9.5+/-.6mm2 versus 11.0+/-.7mm2; P<.05). Moreover, the cross sectional area increased further 5 min after return of spontaneous circulation (9.5+/-.6mm2 versus 14.0+/-.8mm2, P<.05). In conclusion, in this experimental model with normal coronary arteries, AVP resulted in significantly increased LAD coronary artery cross sectional area during normal sinus rhythm, during ventricular fibrillation with CPR, and after return of spontaneous circulation.
Wenzel
Volker
V
Department of Anesthesiology and Critical Care Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. volker.wenzel@uibk.ac.at
Kern
Karl B
KB
Hilwig
Ronald W
RW
Berg
Robert A
RA
Schwarzacher
Severin
S
Butman
Samuel M
SM
Lindner
Karl H
KH
Ewy
Gordon A
GA
D019412:Anatomy, Cross-Sectional; D000818:Animals; D001127:Arginine Vasopressin / Q000008:administration & dosage*; D003331:Coronary Vessels / Q000000981:diagnostic imaging* / Q000187:drug effects*; D004195:Disease Models, Animal; D006323:Heart Arrest / Q000209:etiology / Q000503:physiopathology*; D006439:Hemodynamics; D007275:Injections, Intravenous; D012016:Reference Values; D013552:Swine; D018084:Ultrasonography, Interventional; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*; D014693:Ventricular Fibrillation / Q000150:complications / Q000503:physiopathology
D014662:Vasoconstrictor Agents; D001127:Arginine Vasopressin